BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

135 related articles for article (PubMed ID: 20590345)

  • 1. Clinical aspects of pharmacogenetics of pain and co-morbidities of emotional distress.
    Kamen BA
    Asian Pac J Cancer Prev; 2010; 11 Suppl 1():27-30. PubMed ID: 20590345
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Review of Opioid Pharmacogenetics and Considerations for Pain Management.
    Owusu Obeng A; Hamadeh I; Smith M
    Pharmacotherapy; 2017 Sep; 37(9):1105-1121. PubMed ID: 28699646
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Reviewing pharmacogenetics to advance precision medicine for opioids.
    Magarbeh L; Gorbovskaya I; Le Foll B; Jhirad R; Müller DJ
    Biomed Pharmacother; 2021 Oct; 142():112060. PubMed ID: 34523422
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Genetic predictors of the clinical response to opioid analgesics: clinical utility and future perspectives.
    Lötsch J; Skarke C; Liefhold J; Geisslinger G
    Clin Pharmacokinet; 2004; 43(14):983-1013. PubMed ID: 15530129
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Codeine and opioid metabolism: implications and alternatives for pediatric pain management.
    Chidambaran V; Sadhasivam S; Mahmoud M
    Curr Opin Anaesthesiol; 2017 Jun; 30(3):349-356. PubMed ID: 28323671
    [TBL] [Abstract][Full Text] [Related]  

  • 6. CYP2D6 phenotype-specific codeine population pharmacokinetics.
    Linares OA; Fudin J; Schiesser WE; Daly Linares AL; Boston RC
    J Pain Palliat Care Pharmacother; 2015 Mar; 29(1):4-15. PubMed ID: 25562725
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Pharmacogenetics of opioids.
    Somogyi AA; Barratt DT; Coller JK
    Clin Pharmacol Ther; 2007 Mar; 81(3):429-44. PubMed ID: 17339873
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Pharmacogenetics of opioids: a narrative review.
    Kumar S; Kundra P; Ramsamy K; Surendiran A
    Anaesthesia; 2019 Nov; 74(11):1456-1470. PubMed ID: 31454083
    [TBL] [Abstract][Full Text] [Related]  

  • 9. CYP2D6 polymorphisms and codeine analgesia in postpartum pain management: a pilot study.
    VanderVaart S; Berger H; Sistonen J; Madadi P; Matok I; Gijsen VM; de Wildt SN; Taddio A; Ross CJ; Carleton BC; Hayden MR; Koren G
    Ther Drug Monit; 2011 Aug; 33(4):425-32. PubMed ID: 21743374
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Clinical perspective on the Clinical Pharmacogenetics Implementation Consortium Updated 2014 guidelines for CYP2D6 and codeine.
    Nicholson WT; Formea CM
    Clin Chem; 2015 Feb; 61(2):319-21. PubMed ID: 25301855
    [No Abstract]   [Full Text] [Related]  

  • 11. Pharmacogenetics of pain management in Zimbabwean patients with sickle cell disease.
    Mapira NL; Thelingwani RS; Chikwambi Z; Kuona P; Masimirembwa C
    Pharmacogenomics; 2023 May; 24(7):359-369. PubMed ID: 37248824
    [No Abstract]   [Full Text] [Related]  

  • 12. Pharmacogenetics in palliative care.
    Kleine-Brueggeney M; Musshoff F; Stuber F; Stamer UM
    Forensic Sci Int; 2010 Dec; 203(1-3):63-70. PubMed ID: 20709477
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Utilization of pharmacogenomics and therapeutic drug monitoring for opioid pain management.
    Jannetto PJ; Bratanow NC
    Pharmacogenomics; 2009 Jul; 10(7):1157-67. PubMed ID: 19604091
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Genetic polymorphisms and human sensitivity to pain and opioids].
    Nishizawa D; Nagashima M; Satoh Y; Tagami M; Ikeda K
    Masui; 2009 Sep; 58(9):1093-101. PubMed ID: 19764431
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Opioids and the management of chronic severe pain in the elderly: consensus statement of an International Expert Panel with focus on the six clinically most often used World Health Organization Step III opioids (buprenorphine, fentanyl, hydromorphone, methadone, morphine, oxycodone).
    Pergolizzi J; Böger RH; Budd K; Dahan A; Erdine S; Hans G; Kress HG; Langford R; Likar R; Raffa RB; Sacerdote P
    Pain Pract; 2008; 8(4):287-313. PubMed ID: 18503626
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Pharmacogenetics of neonatal opioid toxicity following maternal use of codeine during breastfeeding: a case-control study.
    Madadi P; Ross CJ; Hayden MR; Carleton BC; Gaedigk A; Leeder JS; Koren G
    Clin Pharmacol Ther; 2009 Jan; 85(1):31-5. PubMed ID: 18719619
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The AmpliChip CYP450 genotyping test: Integrating a new clinical tool.
    de Leon J; Susce MT; Murray-Carmichael E
    Mol Diagn Ther; 2006; 10(3):135-51. PubMed ID: 16771600
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Pharmacogenetics in pain management: the clinical need.
    Webster LR
    Clin Lab Med; 2008 Dec; 28(4):569-79. PubMed ID: 19059063
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Is there a role for therapeutic drug monitoring with codeine?
    Kelly LE; Madadi P
    Ther Drug Monit; 2012 Jun; 34(3):249-56. PubMed ID: 22569351
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Genetics, pain and analgesia].
    Stamer U; Bayerer B; Stüber F
    Anaesthesist; 2006 Jul; 55(7):746-52. PubMed ID: 16625360
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.